NeuralCapitalNavigate the AI Economy
Rising AI Healthcare Company Expanding Across the United States
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) is rapidly emerging as a leader in AI-powered healthcare. The company has secured partnerships with six major U.S. insurers, expanding in-network access to over 7 million patients across major markets like California and New York. Its first revenue-generating quarter in 2025 delivered $0.5 million in sales with an impressive 89% gross margin, underscoring its scalable SaaS model. A recent $2 million NIH grant further validates its AI-driven diagnostic platform and clinical credibility. With rapid expansion, federal recognition, and strong unit economics, Rocket Doctor AI stands positioned at the forefront of the digital health transformation.
Latest Companies
Explore the companies driving the AI revolution. From household names to rising innovators, get context, insights, and performance highlights—all curated to help you invest smarter.
The Intelligence Behind the Dashboard: Cerence and the Economics of Automotive AI
Cerence brings conversational AI into vehicles, combining established automotive relationships, expanding connected services, and improving cash generation with competitive challenges.
Applied AI Grows Up: Inside GoGo AI Network and the Economics of Industrial Intelligence
Applied AI is quietly reshaping industrial systems, not consumer apps. GoGo AI Network invests in enterprise-grade AI companies built for this reality. A recent multi-year Algo8 contract with a global manufacturer highlights growing adoption, recurring revenue potential, and the slow, durable economics of industrial AI.
Kodiak AI and the Quiet Race to Automate America’s Highways
Kodiak AI is advancing autonomous trucking by focusing on long-haul highways where applied artificial intelligence can deliver measurable economic value today. Rather than chasing flashy autonomy promises, the company emphasizes operational discipline, real-world deployment, and incremental progress at the intersection of AI, logistics, and public markets.
Absci: A Small Cap Betting Big on Generative AI for Biologics
Absci is a small cap biotech using generative AI and high-throughput biology to design therapeutic antibodies from scratch. With early clinical programs underway and partnerships with major pharma and technology firms, the company represents a forward-looking approach to modernizing biologic drug discovery.
AI Landscapes
Explore our Landscape Series—deep dives into the key sectors and technologies shaping the AI industry. Get the context you need to spot emerging trends.
Beyond the AI Model: Who Owns the Paying Workflow?
Palantir and Rocket Doctor reveal how AI's commercial value depends on embedded workflows, paying customers, operational adoption and sustainable economics.
The AI Power Problem: Who Profits When Data Centers Run Out of Electricity?
As AI strains electricity infrastructure, Vertiv, GE Vernova and Bloom Energy are positioned to benefit from growing demand for power.
Enterprise AI Grows Up: The Reckoning Behind the Hype
Enterprise AI is shifting from hype to hard economics, as companies scrutinize whether deployments deliver measurable returns. Clear gains are emerging in customer support, software development, and sales efficiency, benefiting firms like Microsoft (MSFT) and Salesforce (CRM). Yet many pilots fail due to poor integration and weak use cases. For investors, the focus is narrowing to companies that convert AI adoption into durable margin expansion.
Beyond Silicon: How the AI Boom Could Lift Companies Like OKLO and Aduro
The AI boom is reshaping real industries beyond silicon. Companies like OKLO, developing small nuclear reactors, and Aduro Clean Technologies, advancing chemical recycling, illustrate how power and material bottlenecks become investment frontiers. Both reveal how “second-order” beneficiaries—energy and recycling innovators—may quietly ride the next wave of AI-driven growth.
Latest Videos
Watch fast, insightful breakdowns with 3-minute explainers, company spotlights, and market recaps. Get the key takeaways you need, in a format built for smart, quick consumption.
Seeing Smarter: The Future of AI-Powered LiDAR and Perception Systems
AEye (NASDAQ: LIDR) is pioneering the future of machine perception through its AI-enhanced, software-defined LiDAR systems. Unlike traditional fixed-scan LiDAR, AEye’s adaptive sensors dynamically adjust resolution, range, and frame rate in real-time — enabling a smarter, more responsive vision stack across multiple domains. From advanced driver-assistance systems (ADAS) to military-grade targeting and smart infrastructure, AEye’s versatile platform bridges performance and flexibility. As a small-cap, high-risk player, it sits at the cutting edge of autonomy innovation. With deep tech capabilities and multi-sector applicability, AEye may emerge as either a transformational breakthrough or a prime acquisition target.
Autonomy in the Field: Why Palladyne AI Could Be a Strategic Sleeper
Palladyne AI (NASDAQ: PDYN) is an emerging player in the AI and robotics space, developing intelligent autonomy software that allows machines to operate independently in demanding real-world environments. From defense bases to industrial logistics hubs, their technology is designed for high-stakes, high-complexity settings where speed, precision, and reliability matter. The company was formerly known as Sarcos Robotics — a name with more than three decades of engineering and R&D behind it — but in 2024, it rebranded and restructured to focus squarely on AI-driven autonomy. That pivot is already yielding results. With a growing portfolio of Department of Defense contracts, a recently announced partnership with Warner Robins Air Logistics Complex, and new inclusion in the Russell 3000 and 2000 indexes, Palladyne is building real traction. For investors seeking early exposure to the infrastructure layer of AI — not just consumer-facing applications — PDYN offers a rare, small-cap opportunity at the intersection of software, robotics, and national security.
Elbit Systems: The AI Contractor Wiring the Battlefield for Autonomy
Elbit Systems (NASDAQ: ESLT) is a $9 billion defense technology leader quietly driving the militarization of artificial intelligence. From AI-powered drones to robotic ground vehicles and battlefield simulators, Elbit is embedding real-time autonomy into the backbone of modern warfare. Operating globally with deep ties to NATO and U.S. defense, the company blends rugged hardware with edge AI to deliver smart, deployable systems today—not in theory. With strong financials, a hybrid autonomy philosophy, and a broad defense portfolio, Elbit offers investors rare exposure to battlefield-ready AI systems reshaping the future of combat.